Patents by Inventor Fred Immermann

Fred Immermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for monitoring drug activities in vivo
    Patent number: 7643943
    Abstract: Methods, systems and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. Numerous drug activity genes can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells are modulatable by CCI-779 or other drugs. Therefore, these genes can be used as surrogate markers for detecting or monitoring drug activities in vivo.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: January 5, 2010
    Assignee: Wyeth LLC
    Inventors: Michael E. Burczynski, Joseph Boni, Andrew J. Dorner, Natalie C. Twine, Jennifer Stover, William L. Trepicchio, Virginia Fitzpatrick, Fred Immermann
  • Methods for prognosis and treatment of solid tumors
    Publication number: 20080032299
    Abstract: Solid tumor prognosis genes, and methods, systems and equipment of using these genes for the prognosis and treatment of solid tumors. Prognosis genes for a solid tumor can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells (PBMCs) are correlated with clinical outcome of the solid tumor. The prognosis genes of the present invention can be used as surrogate markers for predicting clinical outcome of a solid tumor in a patient of interest. These genes can also be used to select a treatment which has a favorable prognosis for the solid tumor of the patient of interest.
    Type: Application
    Filed: March 8, 2007
    Publication date: February 7, 2008
    Applicant: Wyeth
    Inventors: Michael Burczynski, Natalie Twine, William Trepicchio, Andrew Strahs, Fred Immermann, Donna Slonim, Andrew Dorner
  • Methods for prognosis and treatment of solid tumors
    Publication number: 20060194211
    Abstract: Solid tumor prognosis genes, and methods, systems and equipment of using these genes for the prognosis and treatment of solid tumors. Prognosis genes for a solid tumor can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells (PBMCs) are correlated with clinical outcome of the solid tumor. The prognosis genes of the present invention can be used as surrogate markers for predicting clinical outcome of a solid tumor in a patient of interest. These genes can also be used to select a treatment which has a favorable prognosis for the solid tumor of the patient of interest.
    Type: Application
    Filed: April 29, 2004
    Publication date: August 31, 2006
    Inventors: Michael Burczynski, Natalie Twine, William Trepicchio, Andrew Strahs, Fred Immermann, Donna Slonim, Andrew Dorner